Breast Cancer Awareness Month Cedars-Sinai Cancer Experts Available for Interviews Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 29 September 2022 07:30 AM America/Los_Angeles Breast Cancer Awareness Month Cedars-Sinai Cancer Experts Available for Interviews Pioneering breast cancer surgeon Armando E. Giuliano, MD, is regional medical director of the Cedars-Sinai Cancer Breast Oncology Program. Photo by Cedars-Sinai. WHAT As Breast Cancer Awareness Month begins, Cedars-Sinai Cancer experts are available to discuss new treatments for breast cancer patients and the innovative ways Cedars-Sinai Cancer is making those treatments accessible to all. For example, the Equitable Pathways to Cures for Breast Cancer program aims to increase the number of people of color participating in clinical trials. Increasing minority patients' participation brings promising treatments to more patients and helps underserved communities get equitable access to the latest medical breakthroughs. About 42,000 women in the U.S. will die from breast cancer this year, according to the American Cancer Society, and 1 in 8 women will be diagnosed with breast cancer during her lifetime. WHO Armando E. Giuliano, MD, oversees these efforts as regional medical director of the Cedars-Sinai Cancer Breast Oncology Program. A pioneering breast cancer surgeon and researcher who has spent more than 40 years treating patients, Giuliano radically changed breast cancer treatment by introducing sentinel lymph node biopsy in the early 1990s, thus sparing many women the need for major breast cancer surgery. Yuan Yuan, MD, PhD, is director of Breast Oncology at Cedars-Sinai Cancer. She specializes in triple-negative breast cancer and breast cancer immunotherapy, and is available to speak about breast cancer subtypes, including the recently recognized HER2-low subtype. Jeannie Shen, MD, is medical director for the Breast Program at Huntington Hospital, an Affiliate of Cedars-Sinai. A fellowship-trained breast surgeon who is board-certified in general surgery, Shen has spent more than a decade as a breast surgeon. She is available for interviews in English and Mandarin. Farin Amersi, MD, is the division chief of Surgical Oncology and an associate professor of Surgery at Cedars-Sinai. She is available to discuss the latest innovations in surgical oncology and reconstruction. Lauren DeStefano, MD, is a breast surgical oncologist who is part of the growing ranks of cancer specialists at Cedars-Sinai Cancer in Tarzana. DeStefano primarily treats early-stage breast cancer that is curable with surgery and follow-up treatment. Her mother and grandmother are both breast cancer survivors, and they inspired her longtime interest in breast care. Sylvia S. Estrada, RN, is a nurse practitioner at the Cedars-Sinai Saul and Joyce Brandman Breast Center—A Project of Women’s Guild at the Samuel Oschin Comprehensive Cancer Institute. She specializes in patient education and is available for interviews in English and Spanish. WHERE Cedars-Sinai can accommodate many virtual interview formats, including Zoom, FaceTime and Skype. WHEN Breast Cancer Awareness Month is Oct. 1-31. CONTACT Christina Elston 626-298-0702 [email protected]. Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories Cancer Patient Sails Again A Tumor on Her Spine Kept Jeannea Jordan Ashore but Her Cedars-Sinai Neurosurgeon Got Her Back on Her Boat September 19, 2022 06:00 AM America/Los_Angeles Jeannea Jordan, who turns 80 in October, is a local sailing pioneer who began racing and cruising her 30-foot sailboat 25 years ago when few women were part of the sport. When a tumor on her spine ran her aground last year and her oncologist at … Read more Study Active Surveillance an Effective Option for Thyroid Cancer Research Published in JAMA Oncology Determines Many Low-Risk Thyroid Cancers Can Be as Effectively Managed With Monitoring as With Surgery September 15, 2022 08:01 AM America/Los_Angeles A novel clinical trial from Cedars-Sinai Cancer shows that active surveillance is an effective treatment for many low-risk thyroid cancer patients. The study, published in JAMA Oncology, also showed for the first time that patients who opted for … Read more Study Patients Prefer Stool Test to Colonoscopy Cedars-Sinai Investigators Find Nearly Three-Quarters of Study Participants Prefer Less-Invasive Option for Colorectal Cancer Screening September 12, 2022 10:00 AM America/Los_Angeles Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.Unlike colonoscopies, FIT doesn’t require lengthy preparation, … Read more Show previous items Show next items Contact the Media Team Email: [email protected] Contact Christina ElstonSenior Communications Specialist Christina.Elston@cshs.org Share this release Breast Cancer Awareness Month Cedars-Sinai Cancer Experts Available for Interviews Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Follow us on Twitter (opens in new window) Visit our Facebook page (opens in new window) (opens in new window) Visit our Youtube profile (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster? Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home